prism (version 9.5) (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
prism (version 9.5)
Prism (Version 9.5), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+version+9%2E5/prism+software/pm40546088-359-6-6
Average 90 stars, based on 1 article reviews
Prism (Version 9.5), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+version+9%2E5/prism+software/pm40546088-359-6-6
Average 90 stars, based on 1 article reviews
prism (version 9.5) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: On-Chip De Novo Production of mRNA Vaccine in Lipid Nanoparticles. Article Snippet: Statistical analyses were conducted using Article Title: Virtual Reality in Preclinical Orthognathic Surgery Education for Dental Students. Article Snippet: The collected data were transformed, processed and analysed using SPSS software (version 17.0) and Article Title: Design and Development of a Syringe-Based POCT Prototype Using Track-Etched PET Membranes for Simple and Rapid Detection of Group A Rotavirus in Human Samples. Article Snippet: Point-of-care tests (POCTs) can be applied widely across various epidemiological contexts and clinical situations.. However, many of these tests are manufactured in high-income countries (HICs), making them less accessible and affordable for lowand middle-income countries (LMICs).. In this study, we present a proof of concept for a simple syringe-based assay (SBA) biosensor that uses PET track-etched membranes (PET-TMs) for the rapid and cost-effective visual detection of group A Rotavirus (RVA) in human samples. Article Title: Peripheral MicroRNA Signatures in Adolescent Depression Article Snippet: Statistical analysis and plots were done using Article Title: Predicting progression-free survival using dynamic contrast-enhanced imaging-based radiomics in advanced nasopharyngeal carcinoma patients treated with nimotuzumab. Article Snippet: Purpose The purpose of this study was to explore the potential value of the radiomics model based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), compared with the clinical model mostly based on the epidermal growth factor receptor (EGFR) expression, in predicting progression-free survival (PFS) in patients with locally advanced nasopharyngeal carcinoma (LA-NPC) treated with nimotuzumab (NTZ).. Methods A total of 136 patients with LA-NPC who received NTZ treatment between January 2018 and June 2022 were included in this study.. Patients were randomly divided into training (n= 95) and validation (n= 41) groups in a 7:3 ratio. Article Title: Biomimetic photosynthesis nanoreactors based thylakoid synergy with metformin for reversing tumor immunosuppressive microenvironment therapy Article Snippet: The hypoxia-induced immunosuppressive tumor microenvironment (TME) significantly limits the effectiveness of various solid tumor therapies.. In this study, we developed a biomimetic photosynthetic nanoreactor system, termed Met-Tk-PLGA (MTP), by incorporating thylakoid membranes (Tk-M) with PLGA microspheres encapsulating metformin (Met).. This system generates oxygen (O2) in situ within the TME via photosynthesis while releasing Met to reduce cellular O2 consumption, thereby alleviating tumor hypoxia. Article Title: YTHDF2 regulates the adriamycin (ADM) resistance in NKTCL by modulating the m6A modification of SLC16A9. Article Snippet: Statistical analysis was performed using Article Title: Unveiling fatal risk factors: Predicting hemophagocytic lymphohistiocytosis in SFTS patients. Article Snippet: Statistical analyses were conducted using |